MedPath

Examination of intraoperative use of tranexamic acid in patients undergoing radical hysterectomy

Not Applicable
Conditions
uterine cancer
Registration Number
JPRN-UMIN000009226
Lead Sponsor
Tokyo Metropolitan Tama Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria are atrial fibrillation,coronary artery disease treated with drug eluting stent,severe chronic renal failure,congenital or acquired thrombophilia,and known or suspected allergy to tranexamic acid.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
intraoperative blood loss
Secondary Outcome Measures
NameTimeMethod
the rate of intraoperative transfusion,perioperative complication rate
© Copyright 2025. All Rights Reserved by MedPath